|
Continuous ESP Block in Patients Undergoing CABG Surgery.
RECRUITINGPhase 3Sponsored by Instituto do Coracao
Actively Recruiting
PhasePhase 3
SponsorInstituto do Coracao
Started2024-12-12
Est. completion2027-12-12
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07666178
Summary
This study addresses articles and studies related to the erector spinae plane (ESP) block and its technique, advantages and disadvantages, applicability, among others. It aims to provide more information about this block, which is relatively new, and how it can be explored in the anesthesiologist's routine, mainly inserted in the anesthesia scenario for cardiac surgery with a focus on postoperative analgesia.
Eligibility
Healthy volunteers accepted
Inclusion Criteria: * Consent to the free and informed consent term. * Patient undergoing coronary artery bypass graft surgery with cardiopulmonary bypass (CPB). * Preserved left ventricular global function (LVEF \> 50%). Exclusion Criteria: * Moderate or severe valvular dysfunction. * Previous anterior sternotomy. * Known allergy to the study drugs. * Complications during catheter insertion or block placement. * Pre-existing diagnosed chronic pain under treatment. * Concomitant use of drugs with a long half-life (induction and anesthetic maintenance doses will be standardized; patients taking medications with a long half-life are excluded to prevent bias in outcome assessment). * Concomitant administration of Magnesium Sulfate.
Conditions2
Erector Spinae Plane BlockHeart Disease
Interventions3
Related trials
- Dexmedetomidine Ropivacaine Versus Plain Ropivacaine in Bilateral Pectoralis Nerve (PECS) Block — Fayoum University
- Intrapleural Ropivacaine Infusion in Cardiac Surgery — Saint Petersburg State University, Russia
- Evaluating Hemidiaphragmatic Paralysis With Prolonged Neural Blockade From an Interscalene Brachial Plexus Block — Duke University
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 3
SponsorInstituto do Coracao
Started2024-12-12
Est. completion2027-12-12
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07666178